ARCHIVES

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

This article is from The Cancer Letter archive.

Vol. 13 No. 26 | June 26, 1987

Download PDF Visit The Full Archive

Related Articles

What Research Will, Will Not Be Funded At Various Levels – FY 1997 ZBB

October 14, 1977

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008